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Introduction: Spindle cell rhabdomyosarcoma of the head and neck is a very rare tumor in adults. We report on
one case with long-term survival.
Case presentation: A 41-year-old nonsmoking Caucasian man presented in June 2007 with a painless swelling under
his tongue. A diagnosis of a soft tissue sarcoma, and a myofibrosarcoma in particular, was made via biopsy. After
multimodal treatment, including local and systemic therapy, our patient remained disease-free until September 2010.
The local recurrence was treated unsuccessfully with various chemotherapy regimens. In September 2011, our patient
underwent surgical resection again, and a spindle cell rhabdomyosarcoma was diagnosed. To analyze the mismatch
between the original diagnosis of a myofibrosarcoma and the second diagnosis, the two specimens were reassessed,
and a final diagnosis of a spindle cell rhabdomyosarcoma was made. In 2012 and 2013, our patient suffered further
recurrences that were surgically treated, and he is still alive with disease six years and 10 months after the initial
diagnosis in June 2007.
Conclusions: In adults, the spindle cell rhabdomyosarcoma tumor is very rare in the head and neck region. In contrast
to childhood tumors, spindle cell rhabdomyosarcoma in adulthood is often associated with a poor prognosis. In the
present case, the radical surgical treatment might have helped to prolong the patient’s overall survival, which has
lasted more than six years. To our knowledge, this is the longest overall survival reported so far for this tumor entity in
the head and neck region.
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Most malignancies of the oral cavity are squamous cell
carcinomas. This tumor entity is strongly related to sev-
eral risk factors, such as tobacco and alcohol use [1].
Sarcomas of the head and neck region are very rare tu-
mors that are only found in approximately 1% of all head
and neck malignancies [2,3]. In particular, spindle cell
rhabdomyosarcoma (sc-rms) was first described in the
pediatric population [4]. The occurrence of sc-rms in
adults was first reported by Rubin et al., whereas Mentzel
et al. described sclerosing pseudovascular rhabdomyosar-
coma, an additional morphological variant of sc-rms in
adults [5,6]. In contrast to sc-rms in childhood, sc-rms* Correspondence: hartmann_s2@ukw.de
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unless otherwise stated.tumors are very aggressive and associated with a poor
prognosis in adults [7]. In further contrast to sc-rms in
childhood and adolescence, when the genitourinary tract
and the orbital site are most commonly affected, the loca-
tion of sc-rms in adults is mainly the head and neck re-
gion, except for the orbital site [8,9], and the deep soft
tissue of the extremities [10,11]. Furthermore, Esnaola and
colleagues showed that common predictors of survival,
such as location, nodal status and histological subtype,
are not useful for predicting rhabdomyosarcomas in
general. The key factors for predicting overall survival
are more likely metastatic disease at presentation, a poor
response to chemotherapy, tumor size and a negative mar-
gin status after primary resection [8,10,12]. The impact of
age on survival is still a controversial subject [8,10,12]. Al-
though the data available on the prognostic effects of gen-
etic characteristics is still limited, the PAX3-FOXO1 fusionral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ated with alveolar rhabdomyosarcoma, seem to be related
with a worse prognosis because of earlier metastatic spread
[13,14]. However, no distinct genetic signature has been re-
ported for sc-rms thus far, although certain cases feature a
loss of heterozygosity in chromosome 11p15.5 [15].
Because of the very low incidence of these tumors,
clinical knowledge of head and neck rhabdomyosar-
coma treatment in adults is very poor, and this treat-
ment leads to unsatisfying results (Table 1).
Case presentation
A 41-year-old nonsmoking Caucasian man presented in
June 2007 with a painless swelling under his tongue, which
was originally thought to be a sialadenitis of the sublingual
or submandibular gland. Shortly afterward, a diagnosis of a
soft tissue sarcoma, and a myofibrosarcoma in particular,
was made via biopsy at another hospital. The following
workup revealed no regional or distant spread. The chosen
aggressive multimodal treatment was a modified version of
a pediatric cooperative soft tissue protocol published
in 2002 by the Cooperative Weichteil-Sarkomstudie
(CWS) of the Society of Pediatric Oncology. Initially,
our patient received three cycles of multiagent chemother-
apy (vincristine, dactinomycin and ifosfamide), followed
by radiographic restaging. Thereafter, our patient under-
went surgical resection, including a radical neck dissection
of levels I and IIa on both sides. The original tumor showed
a size of 1.3cm in its greatest dimension and blurred edges,
with a focal extension into the preepiglottic space margin
(R1). Postoperatively, two more cycles of the same multi-
drug chemotherapy regimen were given in combination
with external beam radiation (51 Gray (Gy)) to prevent
local treatment failure. Until September 2010, our patient
remained disease-free. He then developed local recurrence
on the floor of his mouth, without signs of metastaticTable 1 Short overview of the survival rate of similar
cases reported in the past
Age (years) Sex Follow-up (month) References
49 F Died of therapeutic complications (1) [11]
51 M Alive without evidence of disease (48) [7]
38 F Died of disease (27) [9]
21 F Alive without evidence of disease (24) [9]
38 M No evidence of disease (1) [9]
18 M Alive with disease (17) [9]
22 M Alive with disease (16) [9]
26 F Alive without evidence of disease (12) [9]
18 F Died of disease (20) [16]
19 M Died of disease (8) [16]
33 F No evidence of disease (1) [17]
F, female; M, male.spread. Our patient was unsuccessfully treated with vari-
ous chemotherapy regimens (paclitaxel + gemcitabine;
Adriamycin® + ifosfamide; Adriamycin® + dimethyl-
triazeno-imidazole-carboxamide (DTIC); and Yondelis®
(trabectedin)). By August 2011, the tumor had reached a
size of 11cm in its greatest dimension, which was the rea-
son for a consult at our department (Oral and Maxillo-
facial Plastic Surgery) at the University Hospital of
Würzburg (Figure 1). After restaging, our patient under-
went total glossectomy with modified radical neck dissec-
tion on both sides. The epiglottis was removed, but the
larynx was preserved. A wide resection of skin in the neck
area was also necessary. Reconstruction of the several de-
fects was performed with a latissimus dorsi free flap from
the left side (Figure 2). The tumor was diagnosed as an
adulthood sc-rms. To analyze the mismatch between the
original diagnosis and the second diagnosis, we requested
and reevaluated the slides of the original tumor specimen
and accordingly corrected the former diagnosis of a myofi-
brosarcoma to a diagnosis of an adulthood sc-rms. Given
negative surgical margins and the previously administered
chemotherapies, our patient was discharged after three
weeks in a good general condition, without any additional
treatment beyond speech therapy. In September 2012,
local recurrence in the anterior floor of the mouth was di-
agnosed and resected. Magnetic resonance imaging of the
neck showed several suspicious lymph nodes in the nuchal
area. Thereafter, a modified level III re-neck dissection
(Robbins) was performed, and the locoregional disease
was confirmed by histology. The reoperation was very well
tolerated by our patient. This was again followed by a
strict follow-up with close intervals. In May 2013, a thirdFigure 1 A preoperative magnetic resonance imaging scan in
August 2011. The entire floor of the mouth, including the tongue,
is filled by the tumor.
Figure 2 Intraoperative situs after temporary mandibulotomy and tumor resection.
Figure 3 Rhabdomyoblasts are loosely scattered between the
spindle cells (hematoxylin and eosin, original magnification
x 100).
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tion of the anterior floor of the mouth, parts of the latissi-
mus dorsi flap, the sternocleidomastoid muscle, the right
thyroid cartilage and the lateral pharyngeal wall had to be
performed. Because of a pathological fracture of the anter-
ior lower jaw that was caused by extensive tumor infiltra-
tion, parts of the lower jaw had to be removed as well, and
continuity could not be obtained. To date, the patient is
still alive with disease and is nourished via a percutaneous
endoscopic gastrostomy (PEG) feeding tube.
Macroscopically, the resection specimen of the first
local recurrence (August, 2011) weighed 724g and con-
tained a well-demarcated tumor measuring 11×8×8cm,
without any invasion of the surrounding structures, in-
cluding the extremely edematous tongue, epiglottis and
skin. The cut surface of the tumor was white, firm and
fleshy, without hemorrhage or necrosis. Microscopically,
the tumor showed variable cellularity and was predom-
inantly composed of spindle-shaped tumor cells with
pale eosinophilic, partially ill-defined cytoplasm; an oval,
tapered nucleus; vesicular chromatin; and mostly small
eosinophilic nucleoli. In certain areas, morphologically,
the tumor cells appeared more rounded and epithelioid.
The tumor predominantly consisted of highly cellular
areas characterized by an arrangement of long and inter-
secting fascicles of the neoplastic spindle cells, partially
resembling a herringbone growth pattern. Occasionally,
there were also regions with shorter fascicles of spindle
cells surrounded by a collagen matrix. There was no sign
of hyaline sclerosis of the intercellular matrix. Admixedthroughout the tumor were a variable number of spindle-
shaped and tadpole-like rhabdomyoblasts with abundant
sparkling eosinophilic cytoplasm, an eccentrically placed
nucleus and rare cross-striation. The rhabdomyoblasts
were mostly loosely scattered between the spindle cells
(Figure 3) and were not very obvious. However, there
were also certain areas with lower cellularity and a
conspicuous gathering of rhabdomyoblasts. Overall,
the rhabdomyoblasts were the most significant mor-
phological clue suggesting the correct diagnosis on con-
ventional light microscopy [7]. Mitoses, including atypical
Figure 4 Distinctive morphology of the spindle cell
rhabdomyosarcoma, as indicated by (A) hematoxylin and eosin
staining and immunohistochemical staining for (B) desmin and
(C) myogenic differentiation 1 (original magnification x 100).
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high-power field = 0.53mm for the microscope used).
Focal tumor necrosis was present, accounting for less than
1% of the total tumor volume. There was no obvious lym-
phangioinvasion or hemangioinvasion and no detectable
invasion of the surrounding structures matching the gross
description. All surgical resection margins were negative,
as were all 52 lymph nodes.
Immunohistochemically, the spindle cells partially
expressed and the rhabdomyoblasts uniformly expressed
desmin (Figures 4 and 5), whereas h-caldesmon staining
remained negative. Furthermore, most rhabdomyoblasts
and certain spindle cells showed specific nuclear positiv-
ity for the myogenic determination factors myogenin
and MyoD1 (Figure 4). Actin exhibited focal positivity,
with an accentuation at the periphery of the tumor.
There was no immunoreactivity of the pan-cytokeratin
marker KL1, and no S100, CDK4, MDM 2 or CD117
was detected.
In conclusion, the morphology and the immunophe-
notype led to the diagnosis of an sc-rms. Furthermore,
these features indicated a tumor stage (TNM, 7th edi-
tion, 2010) of yrpT2b yrpN0 (0/52) L0 V0 Pn0, a resec-
tion status of R0 and a grade G3 tumor with six points
in La Fédération Nationale des Centres de Lutte Contre
le Cancer (FNCLCC) grading.
Additionally, we directly compared the morphology of
the primary tumor specimen and our specimen from the
first local recurrence, which showed the same histological
features. To finally prove that these two specimens con-
tained the same tumor entity, we complemented the pri-
mary immunohistochemical battery with tests for the
specific markers of skeletal muscle differentiation myoglo-
bin and MyoD1, which showed the same nuclear expres-
sion as described above. Therefore, a diagnosis of a sc-rms
was made.
In the following resection specimens (2012 and 2013),
including regional lymph nodes, the tumor tissue showed
histology identical to that of the tumor described above,
corresponding to further local recurrences and regional
spread to lymph nodes, respectively.
Discussion
The herein described case of an sc-rms of the head and
neck region is very rare. The fact that the specimen
was initially misinterpreted as a myofibrosarcoma em-
phasizes the difficulty in the histopathological diagno-
sis of these very uncommon entities. In this case, the
herringbone growth pattern and the immunoreactivity
of desmin and actin represent a diagnostic pitfall, re-
sembling a myofibrosarcoma. However, the admixture
of rhabdomyoblasts between the spindle cells and the
expression of specific striated muscle markers led to
the diagnosis of an sc-rms [15].Of particular interest in this case is the patient’s overall
survival of 82 months since his primary diagnosis in 2007,
which is, to our knowledge, the longest overall survival of
an adult patient with an sc-rms in the head and neck re-
ported so far. When sc-rms was described for the first
time in adults, Rubin et al. hypothesized a very poor out-
come with short survival, which was modified by a larger
Figure 5 Immunohistochemical staining of desmin (original
magnification x 40).
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itionally, this case is consistent with the observation that a
good response to chemotherapy prolongs overall survival
[12] and maximizes the metastasis-free period [8], which
is related to a good prognosis. After the primary multi-
modal therapy, our patient had a disease-free survival
period of 38 months, and he is still lacking distant metas-
tases. Moreover, most adult patients affected with sc-rms
suffer from a neoplasm of the head and neck region
(56.25%) and are male (68.75%). The presented case is
consistent with Nascimento’s study concerning sex, loca-
tion and the possibility of long-term survival [9]. The
poorer prognosis of adult sc-rms is in striking contrast to
the prognosis of childhood sc-rms, which could be be-
cause older patients are less tolerant of intensive chemo-
therapy and that their tumors are less chemosensitive [8].
Furthermore, in adults, the location in the head and neck
region might lead to less aggressive surgical treatment for
esthetic reasons and limits the use of wide surgical mar-
gins [9]. The radical surgical treatment performed in the
presented case could have helped to prolong the patient’s
overall survival until today. This treatment might particu-
larly be the reason for the patient’s long survival with dis-
ease because most patients rapidly die of the disease after
recurrence [8]. Moreover, from a surgical perspective, it is
important that tumor-free margins in a histopathological
examination cannot predict the absence of local recur-
rence in the future. In particular, in the case of sarcoma,
short follow-up intervals with radiographic control are ne-
cessary to detect locoregional recurrence.
Conclusions
In cases of painless swelling in the head and neck region,
rare differential diagnoses, such as sarcoma, should par-
ticularly be taken into consideration. In addition, an
exact histopathological examination is needed becauseindividually adapted therapy regimens are essential to
properly treat affected patients. Despite aggressive surgical
resection with free margins, local recurrence is common.
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